Representative Structural Formula (Image 01)
Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 0338-0008
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 0338-0008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Representative Vial Label (Image 02)
Fosaprepitant Carton Label (Image 03)
Fosaprepitant is a medication that comes in the form of a sterile powder for injection in a vial containing 150 mg of the active ingredient. It is used in a clinical setting, with instructions on how to mix it with a sodium chloride solution to create a solution for injection. The medication is only intended for intravenous administration and should not be taken by mouth. The medication should be reconstituted with 0.9% sodium chloride solution and has a shelf life of approximately two years. Commercially, it is available under the trademarked name Buter.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
